Otorhinolaryngologic Diseases  >>  mometasone furoate nasal spray  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mometasone furoate nasal spray / Generic mfg.
NCT00618332: Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?

Completed
N/A
40
US
mometasone furoate nasal spray, Nasonex, placebo, placebo comparator for Nasonex
University of Chicago, Schering-Plough
Seasonal Allergic Rhinitis
07/08
07/10
NCT01199757: A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures

Completed
N/A
540
NA
Fluticasone furoate, AVAMYS™, mometasone furoate, NASONEX™, fluticasone propionate, FLIXONASE™
GlaxoSmithKline, Adelphi Real World
Rhinitis, Allergic, Perennial
08/09
08/09
RCSS, NCT00967967: Validation of the Rhinitis Control Scoring System

Suspended
N/A
50
Canada
Medication Mometasone furoate and desloratadine, Nasonex, Aerius
Laval University
Asthma, Rhinitis
06/14
09/14

Download Options